News

Some of the biggest beneficiaries of the artificial intelligence (AI) boom are semiconductor stocks. That includes Arm Holdings (NASDAQ: ARM), which plays an important role in the chip space by

With its shares up 84% year to date, Palantir Technologies (NYSE: PLTR) has been having a good run, especially after better-than-expected second-quarter earnings show accelerating growth following

Niche artificial intelligence (AI) company Tempus AI (NASDAQ: TEM) is a stock recently listed on the exchange that is making significant moves. On news that one of these was a strategic investment

As we all know, the weight-loss drug revolution is making a lot of companies rich, and the party's just getting started. Weight-loss drug developers like the Danish biotech Zealand Pharma (OTC:

Sophisticated semiconductor chips known as graphics processing units (GPU) play an important role in the development of artificial intelligence (AI).

One thing some investors might not realize

Image source: The Motley Fool.

Medtronic (NYSE: MDT)Q1 2025 Earnings CallAug 20, 2024, 8:00 a.m. ET

Ryan Weispfenning -- Vice President and Head, Investor Relations

Continue reading

Source Fool.com

Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) recently fell behind in their race with Moderna (NASDAQ: MRNA) to develop new combination shots that could be worth billions in annual sales. Top-line

The stock market remains one of the best ways to grow capital over time. And although having millions in the bank might help, a more accessible -- and perfectly sensible -- strategy is to invest

If you're looking for stocks on sale in the current market, despite the broader gains that major indices have clocked, many companies have responded in different ways. While a stock trading at a

Pharmaceutical giant Pfizer (NYSE: PFE) has been in a bit of a freefall since early 2022, with shares down by 46%. Pfizer's revenue and earnings dropped off a cliff along with its

What do income investors like better than a stock that pays a juicy dividend yield? The answer is easy: A stock with a juicy dividend yield that's likely to grow its dividend payout over time.

Such

Many stocks have been enjoying major gains as the bull market has persisted, driving up shares prices of companies across various indexes. If you're investing for the long term, what's more

You might think that if a drugmaker has a top-selling drug, it would be a lock to be a top-performing stock and a no-brainer buy. That may be true in some cases. In others, it can be a source of

There are many reasons investors love dividends. For one, the companies that pay them are generally more stable because unhealthy companies aren't in a position to return value to shareholders in

If you're a retiree looking to make the most of your nest egg, putting money into dividend stocks can be a great way to do that. You can help maximize the recurring income you earn by investing in

If you're buying a dividend stock, you need to carefully consider not just the payout ratio but also the company's long-term prospects. Intel suspended its dividend recently, an example of a

The recent stock market sell-off appears to have fizzled out and now could be a great time for long-term investors to put some of their cash to work.

Three Motley Fool contributors think they've

If you're looking for a top healthcare company to invest in, you may want to consider looking at one that has multiple fast-growing products in its portfolio. By seeking out diversified growth

The much-feted biotech Viking Therapeutics (NASDAQ: VKTX) is aiming for Novo Nordisk's (NYSE: NVO) cash cow, the market for weight loss drugs. If its ambitions are fulfilled, it has a shot at

In the thick of the coronavirus pandemic several years ago, any positive news from a developer of COVID-19 vaccines or drugs would have been met with a surge of buying in its stock. We're not in

A fresh change in leadership, unexpectedly strong preliminary results, and a set of bullish new analyst notes were the main factors pushing Victoria's Secret (NYSE: VSCO) stock higher in recent

Attractive investment opportunities can sometimes arise when investors react emotionally to short-term events. Some of these events revolve around the earnings season, when a company releases

AT&T (NYSE: T) stands out for its dividend with a payout that currently yields over 5.5%. That's one of the highest dividend yields in the S&P 500, where the yield is currently less than 1.5%.

A

The diabetes and obesity care markets are under disruption. Glucagon-like peptide-1 (GLP-1) receptor agonists such as Ozempic, Wegovy, Mounjaro, and Zepbound have catapulted in popularity.

The thing